Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000490001 | SCV000576874 | likely pathogenic | not provided | 2017-04-17 | criteria provided, single submitter | clinical testing | The S26378X variant in the TTN gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. Other nonsense variants in the TTN gene have been reported in Human Gene Mutation Database in association with dilated cardiomyopathy and myopathy (Stenson et al., 2014). Furthermore, S26378X is located in the A-band region of TTN, where the majority of truncating pathogenic variants associated with DCM have been reported (Herman et al., 2012). Additionally, the S26378X variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). Nevertheless, this variant lacks observation in a significant number of affected individuals, segregation data, and functional evidence, which would further clarify its pathogenicity. We interpret S26378X as a likely pathogenic variant. |
CHEO Genetics Diagnostic Laboratory, |
RCV000769922 | SCV000901348 | likely pathogenic | Cardiomyopathy | 2017-07-31 | criteria provided, single submitter | clinical testing |